209 related articles for article (PubMed ID: 18706333)
1. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis.
Gao H; Dong B; Liu X; Xuan H; Huang Y; Lin D
Anal Chim Acta; 2008 Aug; 624(2):269-77. PubMed ID: 18706333
[TBL] [Abstract][Full Text] [Related]
2. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool.
Zira AN; Theocharis SE; Mitropoulos D; Migdalis V; Mikros E
J Proteome Res; 2010 Aug; 9(8):4038-44. PubMed ID: 20527959
[TBL] [Abstract][Full Text] [Related]
3. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.
Yang Y; Li C; Nie X; Feng X; Chen W; Yue Y; Tang H; Deng F
J Proteome Res; 2007 Jul; 6(7):2605-14. PubMed ID: 17564425
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues.
Righi V; Mucci A; Schenetti L; Tosi MR; Grigioni WF; Corti B; Bertaccini A; Franceschelli A; Sanguedolce F; Schiavina R; Martorana G; Tugnoli V
Anticancer Res; 2007; 27(5A):3195-204. PubMed ID: 17970061
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
6. NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse.
Jiang N; Yan X; Zhou W; Zhang Q; Chen H; Zhang Y; Zhang X
J Proteome Res; 2008 Sep; 7(9):3678-86. PubMed ID: 18656976
[TBL] [Abstract][Full Text] [Related]
7. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis.
OuYang D; Xu J; Huang H; Chen Z
Appl Biochem Biotechnol; 2011 Sep; 165(1):148-54. PubMed ID: 21505807
[TBL] [Abstract][Full Text] [Related]
9. NMR spectroscopic-based metabonomic investigation on the acute biochemical effects induced by Ce(NO3)3 in rats.
Wu H; Zhang X; Liao P; Li Z; Li W; Li X; Wu Y; Pei F
J Inorg Biochem; 2005 Nov; 99(11):2151-60. PubMed ID: 16144712
[TBL] [Abstract][Full Text] [Related]
10. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery.
Lin L; Huang Z; Gao Y; Yan X; Xing J; Hang W
J Proteome Res; 2011 Mar; 10(3):1396-405. PubMed ID: 21186845
[TBL] [Abstract][Full Text] [Related]
11. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.
Zheng H; Ji J; Zhao L; Chen M; Shi A; Pan L; Huang Y; Zhang H; Dong B; Gao H
Oncotarget; 2016 Sep; 7(37):59189-59198. PubMed ID: 27463020
[TBL] [Abstract][Full Text] [Related]
12. Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy.
Katz-Brull R; Rofsky NM; Morrin MM; Pedrosa I; George DJ; Michaelson MD; Marquis RP; Maril M; Noguera C; Lenkinski RE
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F637-41. PubMed ID: 15572523
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy.
Wei L; Liao P; Wu H; Li X; Pei F; Li W; Wu Y
Toxicol Appl Pharmacol; 2009 Feb; 234(3):314-25. PubMed ID: 19073202
[TBL] [Abstract][Full Text] [Related]
14. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.
Huo T; Cai S; Lu X; Sha Y; Yu M; Li F
J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171
[TBL] [Abstract][Full Text] [Related]
15. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases.
Gao H; Dong B; Jia J; Zhu H; Diao C; Yan Z; Huang Y; Li X
J Cancer Res Clin Oncol; 2012 May; 138(5):753-61. PubMed ID: 22258851
[TBL] [Abstract][Full Text] [Related]
16. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture.
Wu Q; Zhang Q; Sun B; Yan X; Tang Y; Qiao X; Chen Q; Yu S; Liang F
J Pharm Biomed Anal; 2010 Feb; 51(3):698-704. PubMed ID: 19854601
[TBL] [Abstract][Full Text] [Related]
18. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
19. [Metabonomic study of blood plasma in the assessment of liver graft function].
Zhang Q; Gao J; Li L; Chen HB; Li XQ; Yan XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):725-9. PubMed ID: 18595247
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
Miyake H; Sakai I; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M
Int J Urol; 2009 May; 16(5):465-71. PubMed ID: 19467119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
